Franziska Schaedeli Stark

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Attention Deficit Hyperactivity Disorder

Acute Ischemic Stroke

Top Venues

Journal of pharmacokinetics and pharmacodynamics

CPT: pharmacometrics & systems pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Franziska Schaedeli Stark, Clarisse Chavanne, Michael G M Derks, Koen Jolling, Hendrik Maxime Lagraauw, Lars Lindbom, Klaas Prins, Hanna E Silber Baumann
A population pharmacokinetics model of balovaptan to support dose selection in adult and pediatric populations. Journal of pharmacokinetics and pharmacodynamics 51 (3) (2024)
Franziska Schaedeli Stark, Clarisse Chavanne, Michael G M Derks, Koen Jolling, Hendrik Maxime Lagraauw, Lars Lindbom, Klaas Prins, Hanna E Silber Baumann
A population pharmacokinetics model of balovaptan to support dose selection in adult and pediatric populations. Journal of pharmacokinetics and pharmacodynamics 51 (3) (2024)
Zrinka Duvnjak, Franziska Schaedeli Stark, Valérie Cosson, Sylvie Retout, Emilie Schindler, João A Abrantes
Simulation-based evaluation of the Pharmpy Automatic Model Development tool for population pharmacokinetic modeling in early clinical drug development. CPT: pharmacometrics & systems pharmacology (2024)
Franziska Schaedeli Stark, Clarisse Chavanne, Michael G M Derks, Koen Jolling, Hendrik Maxime Lagraauw, Lars Lindbom, Klaas Prins, Hanna E Silber Baumann
A population pharmacokinetics model of balovaptan to support dose selection in adult and pediatric populations. Journal of pharmacokinetics and pharmacodynamics 51 (3) (2024)
Franziska Schaedeli Stark, Clarisse Chavanne, Michael G M Derks, Koen Jolling, Hendrik Maxime Lagraauw, Lars Lindbom, Klaas Prins, Hanna E Silber Baumann
A population pharmacokinetics model of balovaptan to support dose selection in adult and pediatric populations. Journal of pharmacokinetics and pharmacodynamics 51 (3) (2024)
Franziska Schaedeli Stark, Clarisse Chavanne, Michael G M Derks, Koen Jolling, Hendrik Maxime Lagraauw, Lars Lindbom, Klaas Prins, Hanna E Silber Baumann
A population pharmacokinetics model of balovaptan to support dose selection in adult and pediatric populations. Journal of pharmacokinetics and pharmacodynamics (2024)